Mark Doherty
- Hepatology top 5%
- Oncology top 5%
- Lung Cancer Research Studies 10
- Colorectal Cancer Treatments and Studies 8
- Cancer Immunotherapy and Biomarkers 8
- Pancreatic and Hepatic Oncology Research 7
-
- Lung Cancer Treatments and Mutations 18
- Lung Cancer Diagnosis and Treatment 8
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 9
- Surgery top 10%
- Cholangiocarcinoma and Gallbladder Cancer Studies 13
- Co-authors
- Jennifer J. KnoxNatasha B. LeighlFrances A. ShepherdCatherine LabbéKevin JaoGeoffrey LiuDavid GrantGonzalo Sapisochín
- Journals
- Journal of Clinical Oncology (22 papers)Journal of Thoracic Oncology (4 papers)Annals of Oncology (3 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Mark Doherty
70 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 79
- Hepatology 219
- Oncology 700
- Pulmonary and Respiratory Medicine 508
- Cancer Research 190
- Surgery 326
Countries citing papers authored by Mark Doherty
This map shows the geographic impact of Mark Doherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Doherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Doherty more than expected).
Fields of papers citing papers by Mark Doherty
This network shows the impact of papers produced by Mark Doherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Doherty. The network helps show where Mark Doherty may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Doherty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 7 | |
| 5 | 2022 | 22 | |
| 6 | 2022 | 9 | |
| 7 | 2021 | 7 | |
| 8 | 2020 | 7 | |
| 9 | 2020 | 2 | |
| 10 | 2020 | 59 | |
| 11 | 2020 | 28 | |
| 12 | 2020 | 11 | |
| 13 | 2018 | 2 | |
| 14 | 2017 | 40 | |
| 15 | 2017 | 13 | |
| 16 | 2017 | 202 | |
| 17 | 2016 | 9 | |
| 18 | 2015 | 29 | |
| 19 | 2013 | 13 | |
| 20 | 2011 | 7 |
About Mark Doherty
Mark Doherty is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 74 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers), Lung Cancer Research Studies (10 papers), Cancer Genomics and Diagnostics (9 papers), Lung Cancer Diagnosis and Treatment (8 papers), Colorectal Cancer Treatments and Studies (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Pancreatic and Hepatic Oncology Research (7 papers). The work is most often cited by research in Hepatology (219 citations), Oncology (700 citations) and Pulmonary and Respiratory Medicine (508 citations). Mark Doherty has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Jennifer J. Knox, Natasha B. Leighl, Frances A. Shepherd, Catherine Labbé, Kevin Jao, Geoffrey Liu, David Grant, Gonzalo Sapisochín, M. Russo and Anand Ghanekar. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Lung Cancer and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.